Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Director of Marketing (US)

Phagenesis Ltd
CompanyPhagenesis Ltd
CategoryMarketing
LocationUnited States - Remote
RemoteRemote
EmploymentNot stated
LevelDirector
SalaryNot stated by the employer
Posted19 Jun 2026
Last verified9 Aug 2026
SourceEmployer ATS (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
At Phagenesis, we are committed to transforming lives by eliminating the burden of neurogenic dysphagia. As we transform into a high-performing global organization, we’re looking for exceptional individuals who thrive in fast- paced, evolving environments, and bring a strong sense of ownership and urgency to their work. ​ ​​ Our vision is clear—make  Phagenyx the standard of care in ICU and acute care settings—and we need ambitious,  mission-aligned talent to help us get there. We put patients first, operate with courage and trust, and foster a culture that values innovation, accountability, and a challenger mindset. ​ Role Overview: The Director of Marketing is a senior individual contributor responsible for building and executing Phagenesis’s US downstream commercial marketing engine. Reporting to the VP of Global Marketing, this leader will own the full downstream marketing function — from market-shaping strategy and messaging through to lead generation, pipeline acceleration, and the suite of tools and programmes that equip the field and drive patient access. This is a highly impactful, builder’s role. The right candidate will be equally comfortable developing the strategic framework and rolling up their sleeves to execute. They will be a core thought partner to the commercial team, a steward of the Phagenyx brand, and a force multiplier for the field. Key Responsibilities: Messaging, Positioning & Brand Own and continuously evolve the Phagenyx value proposition — grounded in clinical evidence, health economic impact, and the unmet need in post-stroke dysphagia — ensuring it resonates across clinical, operational, and economic buyer audiences. Develop and maintain a coherent messaging architecture for all key customer segments: neurologists, speech-language pathologists, stroke coordinators, neurocritical care intensivists, hospital administrators, and payers. Ensure consistency and clarity of internal and external communications across all commercial touchpoints. Translate complex clinical data (RCT outcomes, guideline recommendations, healthcare economic outcomes) into compelling, accessible commercial narratives. Lead brand positioning strategy and ensure all materials reflect the Phagenesis brand identity.   Lead Generation & Demand Creation Design and execute multi-channel demand generation programmes targeting acute care hospitals, comprehensive stroke centres, and neurology/critical care services to build a qualified pipeline of prospective Phagenyx sites. Develop and manage digital and field-integrated campaigns leveraging clinical evidence, guideline adoption, and health economic data to drive awareness and inbound interest. Build segmentation models and target account frameworks that enable the field to prioritise and penetrate high-value accounts efficiently. Establish metrics and dashboards to track lead volume, source quality, and conversion rates; optimise programmes based on performance data. Partner with sales leadership to align marketing-generated leads with territory execution priorities.   Deal Velocity & Pipeline Acceleration Develop commercial programmes and content to accelerate movement through the sales funnel — from initial clinical champion identification through stakeholder alignment, hospital approval, and first patient treatment. Build and maintain a suite of objection-handling tools, economic value calculators, ROI models, and payer/reimbursement resources that remove friction at each stage of the deal cycle. Partner with Therapy Development Specialists to identify pipeline bottlenecks and develop targeted interventions — whether clinical education, administrative alignment tools, or C-suite-facing business case materials. Own the development of account-level business case frameworks addressing the dysphagia cost burden, NTAP reimbursement,